期刊
LANCET NEUROLOGY
卷 8, 期 12, 页码 1150-1157出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(09)70238-8
关键词
-
资金
- Medical Research Council [G0701075, G0901254] Funding Source: Medline
- NIA NIH HHS [R01 AG024040] Funding Source: Medline
- Parkinson's UK [G-0907] Funding Source: Medline
- Medical Research Council [G0701075] Funding Source: researchfish
- Parkinson's UK [G-0907] Funding Source: researchfish
- MRC [G0701075] Funding Source: UKRI
To date, there have been few systematic attempts to provide a standard operating procedure for the neuropathological diagnosis of Parkinson's disease (PD). Pathological examination cannot classify the clinical syndrome with certainty; therefore, the neuropathological diagnosis is, at best, a probability statement. The neuropathological diagnosis of parkinsonism has become increasingly based on fundamental molecular underpinnings, with recognition that the genetics of parkinsonism is heterogeneous and includes disorders that are associated with and without Lewy bodies. The advent of a-synuclein immunchistochemistry has substantially improved the ability to identify Lewy pathology, particularly cortical Lewy bodies and smaller aggregates within processes and the neuropil. In this Review we discuss the diagnostic criteria for the neuropathological assessment of PD. These criteria are provisional and need to be validated through an iterative process that could help with their refinement. Additionally, we suggest future directions for neuropathology research on PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据